HSD3B1 Gene Polymorphism and Female Pattern Hair Loss in Women with Polycystic Ovary Syndrome

    Yi-An Tu, Sung-Jan Lin, Pei-Lung Chen, Chiahung Chou, Chu-Chun Huang, Hong Nerng Ho, Mei Chen
    Image of study
    TLDR HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.
    The study found that the HSD3B1 1245C allele and being overweight were positively correlated with the presence of female pattern hair loss (FPHL) in women with polycystic ovary syndrome (PCOS). The study also found that the presence of FPHL in women with PCOS was significantly associated with an increased body mass index, decreased sex hormone binding globulin and high density lipoprotein cholesterol levels, elevated triglyceride levels, and increased prevalence of hypertension. The study suggests that the genetic variant of HSD3B1 may contribute to the development of FPHL in overweight women with PCOS. However, further studies with larger sample sizes are needed to confirm these findings.
    Discuss this study in the Community →

    Research cited in this study

    20 / 20 results

    Related Community Posts Join

    1 / 1 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

    Similar Research

    5 / 93 results